Two Sigma Advisers’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-53,000
| Closed | -$2.45M | – | 477 |
|
|
2025
Q4 | $2.45M | Sell |
53,000
-49,500
| -48% | -$2.07M | ﹤0.01% | 1094 |
|
|
2025
Q3 | $3.59M | Buy |
102,500
+80,900
| +375% | +$2.81M | 0.01% | 869 |
|
|
2025
Q2 | $639K | Sell |
21,600
-24,700
| -53% | -$705K | ﹤0.01% | 1640 |
|
|
2025
Q1 | $1.38M | Sell |
46,300
-25,700
| -36% | -$785K | ﹤0.01% | 1310 |
|
|
2024
Q4 | $2.06M | Sell |
72,000
-145,300
| -67% | -$4.81M | ﹤0.01% | 1110 |
|
|
2024
Q3 | $8.4M | Sell |
217,300
-40,600
| -16% | -$1.45M | 0.02% | 534 |
|
|
2024
Q2 | $8.3M | Sell |
257,900
-9,800
| -4% | -$340K | 0.02% | 594 |
|
|
2024
Q1 | $10.4M | Buy |
267,700
+22,700
| +9% | +$794K | 0.02% | 530 |
|
|
2023
Q4 | $7.54M | Sell |
245,000
-64,000
| -21% | -$1.6M | 0.02% | 648 |
|
|
2023
Q3 | $6.91M | Sell |
309,000
-600
| -0.2% | -$13.7K | 0.02% | 595 |
|
|
2023
Q2 | $6.65M | Buy |
309,600
+132,600
| +75% | +$3.01M | 0.02% | 639 |
|
|
2023
Q1 | $4.25M | Buy |
177,000
+134,500
| +316% | +$3.57M | 0.01% | 873 |
|
|
2022
Q4 | $986K | Buy |
42,500
+29,300
| +222% | +$591K | ﹤0.01% | 1572 |
|
|
2022
Q3 | $211K | Buy |
+13,200
| New | +$233K | ﹤0.01% | 2183 |
|
|
2022
Q2 | – | Sell |
-26,700
| Closed | -$544K | – | 2690 |
|
|
2022
Q1 | $544K | Buy |
26,700
+5,000
| +23% | +$94.5K | ﹤0.01% | 1944 |
|
|
2021
Q4 | $405K | Sell |
21,700
-7,900
| -27% | -$154K | ﹤0.01% | 2014 |
|
|
2021
Q3 | $584K | Sell |
29,600
-27,100
| -48% | -$586K | ﹤0.01% | 1861 |
|
|
2021
Q2 | $1.34M | Sell |
56,700
-28,800
| -34% | -$665K | ﹤0.01% | 1505 |
|
|
2021
Q1 | $2.03M | Buy |
+85,500
| New | +$2.03M | 0.01% | 1262 |
|
|
2020
Q4 | – | Sell |
-46,100
| Closed | -$960K | – | 2420 |
|
|
2020
Q3 | $960K | Sell |
46,100
-64,600
| -58% | -$1.17M | ﹤0.01% | 1515 |
|
|
2020
Q2 | $1.94M | Buy |
110,700
+30,500
| +38% | +$597K | 0.01% | 1218 |
|
|
2020
Q1 | $1.31M | Buy |
80,200
+57,500
| +253% | +$1.19M | 0.01% | 1332 |
|
|
2019
Q4 | $467K | Buy |
+22,700
| New | +$378K | ﹤0.01% | 1903 |
|
|
2019
Q3 | – | Sell |
-29,000
| Closed | -$381K | – | 2250 |
|
|
2019
Q2 | $381K | Buy |
29,000
+1,900
| +7% | +$25.4K | ﹤0.01% | 1918 |
|
|
2019
Q1 | $410K | Buy |
27,100
+4,300
| +19% | +$68.9K | ﹤0.01% | 1865 |
|
|
2018
Q4 | $391K | Sell |
22,800
-8,200
| -26% | -$140K | ﹤0.01% | 1869 |
|
|
2018
Q3 | $457K | Buy |
31,000
+16,000
| +107% | +$284K | ﹤0.01% | 1828 |
|
|
2018
Q2 | $358K | Buy |
+15,000
| New | +$369K | ﹤0.01% | 2042 |
|
Other funds holding COLL
EAM
VCM
